© 2004 by Oxford University Press
© 2004 Oxford University Press
NEWS |
Awards, Appointments, Announcements
Blossom A. Damania, Ph.D., assistant professor of microbiology and immunology at the University of North Carolina at Chapel Hill, was presented the Gertrude B. Elion Cancer Research Award by the American Association for Cancer Research. The award recognizes excellence in cancer etiology, diagnosis, treatment, or prevention. Damania received the award for her work on sarcoma-associated herpesvirus (KSHV) in human malignancies.
Peter N. Schlegel, M.D., has been named chairman of the Department of Urology at Weill Cornell Medical College in New York and urologist-in-chief at New York-Presbyterian Hospital/Weill Medical College. Schlegel is an expert in male infertility and prostate cancer and co-editor of the Journal of Andrology.
David C. Hohn, M.D., has been elected chairman of the board of directors of the National Comprehensive Cancer Network, an international alliance of 19 cancer centers. Hohn is president and chief executive officer of Roswell Park Cancer Institute in Buffalo, N.Y., one of the founding member institutions of the NCCN.
The Society of Surgical Oncology has named S. Eva Singletary, M.D., president of it Executive Council. Singletary, a professor of surgical oncology at the University of Texas M. D. Anderson Cancer Center in Houston, is the first woman to hold the society’s highest office.
Other newly elected council members include: president-elect Timothy J. Eberlein, M.D., Washington University School of Medicine, St. Louis, Mo., vice president Raphael E. Pollock, M.D., Ph.D., University of Texas M. D. Anderson Cancer Center, and secretary Fabrizio Michelassi, M.D., University of Chicago Medical Center.
In addition, Anton Bilchick, M.D., Ph.D., John Wayne Cancer Institute, Santa Monica, Calif., and Douglas B. Evans, M.D., University of Texas M. D. Anderson Cancer Center, have been elected to the council. Charles A. Staley, M.D., Emory University School of Medicine, Atlanta, was elected councilor-at-large.
Memorial Sloan-Kettering Cancer Center announced two new appointments:
James Allison, Ph.D., has been appointed the new chairman of the Immunology Program. Allison comes to Sloan-Kettering from the University of California, Berkeley, where he was a professor in the Division of Immunology and director of the Cancer Research Center.
David Abramson, M.D., has been named chief of the Ophthalmic Oncology Surgical Service. Before joining Sloan-Kettering, Abramson was a clinical professor of ophthalmology at New York-Presbyterian Hospital’s Weill Cornell Medical Center.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||